Joerg Ahlgrimm on Muck Rack

Joerg Ahlgrimm

Verified
France
As seen in: SK pharmteco, Pharmaceutical Technology, Cell & Gene
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joerg

Contact Joerg, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Weathering The Biotech Storm: Accelerating Manufacturing, Controlling Cost, And Managing Risk With A Strategic CDMO Relationship

|
By Joerg Ahlgrimm Verified
| Cell & Gene Verified
By Joerg Ahlgrimm, CEO, Center for Breakthrough Medicines Following an exuberant investment period during the past several pandemic years, strong headwinds are now challenging the biotech industry. Supply chain snags, a scarcity of skilled talent for technical roles, and a skittish investor climate are severely impacting corporate valuations and are causing some retrenchment in early-stage biotechnology companies.
Open in Who Shared Issue with article?
See all 1 licensed articles (2 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified